Advertisement
Screener

Pulse Biosciences, Inc. (PLSE) P/E Ratio

2.8 / 5 stars · 68/120 Roast Me

PULSE BIOSCIENCES, INC. PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

  • PULSE BIOSCIENCES, INC. pe ratio for the quarter ending 2026-06-30 was -24.47, a change of -9.53 year-over-year.
  • PULSE BIOSCIENCES, INC. pe ratio for the quarter ending 2026-03-31 was -19.72, a change of -1.75 year-over-year.
  • PULSE BIOSCIENCES, INC. pe ratio for the quarter ending 2025-12-31 was -12.81, a change of 8.61 year-over-year.
  • PULSE BIOSCIENCES, INC. pe ratio for the quarter ending 2025-09-30 was -16.03, a change of 7.35 year-over-year.
  • PULSE BIOSCIENCES, INC. pe ratio for fiscal 2026 was -24.47.
  • PULSE BIOSCIENCES, INC. pe ratio for fiscal 2025 was -12.81, a change of 8.61 from fiscal 2024.
  • PULSE BIOSCIENCES, INC. pe ratio for fiscal 2024 was -21.42, a change of -5.43 from fiscal 2023.
  • PULSE BIOSCIENCES, INC. pe ratio for fiscal 2023 was -15.99, a change of -14.23 from fiscal 2022.
Available history
2016-06-30 to 2026-06-30
Data captured

Historical PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-24.47$1.96B-$80.06M
2026-03-31-19.72$1.47B-$74.57M
2025-12-31-12.81$932.46M-$72.78M
2025-09-30-16.03$1.2B-$74.73M
2025-06-30-14.94$1.02B-$68.03M
2025-03-31-17.97$1.08B-$60.24M
2024-12-31-21.42$1.15B-$53.59M
2024-09-30-23.39$1.08B-$46.13M
2024-06-30-14.04$618M-$44.02M
2024-03-31-11.31$481.01M-$42.55M
2023-12-31-15.99$674.96M-$42.21M
2023-09-30-5.61$221.61M-$39.47M
2023-06-30-8.39$393.8M-$46.95M
2023-03-31-2.48$126.31M-$51.03M
2022-12-31-1.76$103.14M-$58.51M
2022-09-30-1.32$85.62M-$64.72M
2022-06-30-0.93$56.8M-$60.97M
2022-03-31-2.33$144.84M-$62.29M
2021-12-31-12.83$816.68M-$63.66M
2021-09-30-10.32$640.03M-$61.99M
2021-06-30-8.01$485.54M-$60.61M
2021-03-31-11.04$625.18M-$56.62M
2020-12-31-12.23$609.62M-$49.85M
2020-09-30-5.98$298.17M-$49.89M
2020-06-30-5.4$263.06M-$48.74M
2020-03-31-3.06$149.42M-$48.77M
2019-12-31-5.95$279.26M-$46.97M
2019-09-30-7.62$320.97M-$42.14M
2019-06-30-6.66$274.14M-$41.15M
2019-03-31-9.35$364.29M-$38.96M
2018-12-31-6.29$236M-$37.55M
2018-09-30-6.46$241M-$37.3M
2018-06-30-7.51$255.65M-$34.02M
2018-03-31-7.35$228.25M-$31.04M
2017-12-31-15.53$396.93M-$25.57M
2017-09-30-15.46$304.11M-$19.67M
2017-06-30-33.1$494.95M-$14.95M
2017-03-31-26.22$289.31M-$11.03M
2016-12-31-9.09$86.55M-$9.52M
2016-09-30-10.84$83.75M-$7.73M
2016-06-30-10.47$59.78M-$5.71M

Annual PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-24.47$1.96B-$80.06M
2025-12-31-12.81$932.46M-$72.78M
2024-12-31-21.42$1.15B-$53.59M
2023-12-31-15.99$674.96M-$42.21M
2022-12-31-1.76$103.14M-$58.51M
2021-12-31-12.83$816.68M-$63.66M
2020-12-31-12.23$609.62M-$49.85M
2019-12-31-5.95$279.26M-$46.97M
2018-12-31-6.29$236M-$37.55M
2017-12-31-15.53$396.93M-$25.57M
2016-12-31-9.09$86.55M-$9.52M

Similar stocks

Stock NameCountryMarket CapPE Ratio
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
Heartflow, Inc. (HTFL)United States$4.225B
AtriCure, Inc. (ATRC)United States$3.089B
HAEMONETICS CORP (HAE)United States$4.821B36.52
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87